Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
University of Utah
IRCCS San Raffaele
Canisius-Wilhelmina Hospital
Umeå University
University of Texas Southwestern Medical Center
Dana-Farber Cancer Institute
A.O.U. Città della Salute e della Scienza
Radboud University Medical Center
TC Erciyes University
IRCCS San Raffaele
Kantonsspital Graubuenden
M.D. Anderson Cancer Center
Javeriana University
Odense University Hospital
Radboud University Medical Center